Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur A Levin

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
North Carolina Medical Journal|June 15, 2005
Patient safety: rejecting the status quoArthur A Levin
The New England Journal of Medicine|January 3, 2019
Treating Disease at the RNA Level with OligonucleotidesArthur A Levin
Public Health Reports (Washington, D.C. : 1974)|March 25, 2009
Self-Regulation Is a FailureArthur A Levin
The New England Journal of Medicine|January 5, 2017
Targeting Therapeutic OligonucleotidesArthur A Levin
Nucleic Acid Therapeutics|August 24, 2012
Developing microRNA therapeutics: approaching the unique complexitiesAimee L Jackson, Arthur A Levin
Toxicology and Applied Pharmacology|February 23, 2002
Liarozole markedly increases all trans-retinoic acid toxicity in mouse limb bud cell cultures: a model to explain the potency of the aromatic retinoid (E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1-propenyl] benzoic acidMichael A Pignatello, Frederick C Kauffman, Arthur A Levin
Oligonucleotides|June 13, 2006
Plasma protein binding of an antisense oligonucleotide targeting human ICAM-1 (ISIS 2302)Tanya A Watanabe, Richard S Geary, Arthur A Levin
Circulation Research|February 4, 2012
Developing microRNA therapeuticsEva van Rooij, Angela L Purcell, Arthur A Levin
Current Opinion in Drug Discovery & Development|December 18, 2004
Application of novel quantitative bioanalytical methods for pharmacokinetic and pharmacokinetic/pharmacodynamic assessments of antisense oligonucleotidesRosie Z Yu, Richard S Geary, Arthur A Levin
Journal of Immunotoxicology|October 30, 2008
CpG and Non-CpG oligodeoxynucleotides induce differential proinflammatory gene expression profiles in liver and peripheral blood leukocytes in miceHusam S Younis, Tim Vickers, Arthur A Levin, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
North Carolina Medical Journal|June 15, 2005
Patient safety: rejecting the status quoArthur A Levin
The New England Journal of Medicine|January 3, 2019
Treating Disease at the RNA Level with OligonucleotidesArthur A Levin
Public Health Reports (Washington, D.C. : 1974)|March 25, 2009
Self-Regulation Is a FailureArthur A Levin
The New England Journal of Medicine|January 5, 2017
Targeting Therapeutic OligonucleotidesArthur A Levin
Nucleic Acid Therapeutics|August 24, 2012
Developing microRNA therapeutics: approaching the unique complexitiesAimee L Jackson, Arthur A Levin
Toxicology and Applied Pharmacology|February 23, 2002
Liarozole markedly increases all trans-retinoic acid toxicity in mouse limb bud cell cultures: a model to explain the potency of the aromatic retinoid (E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1-propenyl] benzoic acidMichael A Pignatello, Frederick C Kauffman, Arthur A Levin
Oligonucleotides|June 13, 2006
Plasma protein binding of an antisense oligonucleotide targeting human ICAM-1 (ISIS 2302)Tanya A Watanabe, Richard S Geary, Arthur A Levin
Circulation Research|February 4, 2012
Developing microRNA therapeuticsEva van Rooij, Angela L Purcell, Arthur A Levin
Current Opinion in Drug Discovery & Development|December 18, 2004
Application of novel quantitative bioanalytical methods for pharmacokinetic and pharmacokinetic/pharmacodynamic assessments of antisense oligonucleotidesRosie Z Yu, Richard S Geary, Arthur A Levin
Journal of Immunotoxicology|October 30, 2008
CpG and Non-CpG oligodeoxynucleotides induce differential proinflammatory gene expression profiles in liver and peripheral blood leukocytes in miceHusam S Younis, Tim Vickers, Arthur A Levin, et al.
Pageof 4